Bulletin 2010/45 - European Patent Office
10.02.2013 • Views
Share Embed Flag

Bulletin 2010/45 - European Patent Office

Bulletin 2010/45 - European Patent Office

Bulletin 2010/45 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) II.1(1)<br />

(54) • THERAPEUTISCHE MITTEL ZUM TARGE-<br />

TING DES NC CA-ATP-KANALS UND VER-<br />

WENDUNGSVERFAHREN DAFÜR<br />

• THERAPEUTIC AGENTS TARGETING THE<br />

NC CA-ATP CHANNEL AND METHODS OF<br />

USE THEREOF<br />

• AGENTS THERAPEUTIQUES CIBLANT LE<br />

CANAL NC CA-ATP ET PROCEDES D'UTI-<br />

LISATION ASSOCIES<br />

(73) University of Maryland, Baltimore, 515 West<br />

Lombard Street, 5th Floor, Baltimore, MD<br />

21201-1602, US<br />

Department of Veterans Affairs, <strong>Office</strong> of the<br />

General Counsel-PSG IV (024), 810 Vermont<br />

Avenue NW, Washington, DC 20420, US<br />

(72) SIMARD, Marc, J., Baltimore, MD 21212-<br />

3421, US<br />

(74) Woods, Geoffrey Corlett, J.A. Kemp & Co. 14<br />

South Square, Gray's Inn London WC1R 5JJ,<br />

GB<br />

(60) 10010752.3<br />

A61K 31/675 → (51) C07F 9/38<br />

(51) A61K 31/70 (11) 2 120 968 B1<br />

A61P 9/06<br />

(25) En (26) En<br />

(21) 08713225.4 (22) 23.01.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 25.11.2009<br />

(86) US 2008/0008<strong>45</strong> 23.01.2008<br />

(87) WO 2008/091618 2008/31 31.07.2008<br />

(30) 23.01.2007 US 881940 P<br />

(54) • VERWENDUNG VON D-RIBOSE ZUR<br />

BEHANDLUNG VON VORHOFFLIMMERN<br />

• USE OF D-RIBOSE TO TREAT ATRIAL<br />

FIBRILLATIONS<br />

• UTILISATION DE D-RIBOSE DANS LE<br />

TRAITEMENT DES FIBRILLATIONS AURI-<br />

CULAIRES<br />

(73) Bioenergy Inc., 13840 Johnson Street,<br />

Northeast, Ham Lake, MN 55304, US<br />

(72) HERRICK, James, D., Golden Valley, MN<br />

55432, US<br />

(74) Lucas, Phillip Brian, Lucas & Co. 135<br />

Westhall Road, Warlingham, Surrey CR6<br />

9HJ, GB<br />

A61K 31/727 → (51) C08B 37/10<br />

(51) A61K 33/24 (11) 1 531 836 B1<br />

A61K 38/16 A61K 39/00<br />

A01N 59/16 C07K 1/12<br />

C07K 14/60 C07K 14/635<br />

(25) En (26) En<br />

(21) 03771535.6 (22) 23.05.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 25.05.2005<br />

(86) US 2003/016647 23.05.2003<br />

(87) WO 2004/011599 2004/06 05.02.2004<br />

(30) 24.05.2002 US 383484 P<br />

(54) • POLYPEPTID-SPALTUNGSPROZESS<br />

• POLYPEPTIDE CLEAVAGE PROCESS<br />

• PROCEDE DE CLIVAGE DE POLYPEPTIDE<br />

(73) Medtronic, Inc., 710 Medtronic Parkway,<br />

Minneapolis, MN 55432, US<br />

(72) SEO, Jin Seog, Lincoln, NE 68505, US<br />

HOLMQUIST, Barton, Eagle, NE 68347, US<br />

(74) Leifert & Steffan, <strong>Patent</strong>anwälte Burgplatz<br />

21-22, 40213 Düsseldorf, DE<br />

A61K 38/02 → (51) A61K 38/10<br />

(51) A61K 38/10 (11) 2 033 655 B1<br />

A61K 38/02 A61K 39/395<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

A61K 39/09 C07K 7/00<br />

C12Q 1/00 A61P 31/04<br />

(25) En (26) En<br />

(21) 07301337.7 (22) 04.09.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(43) 11.03.2009<br />

(54) • Verwendung von Verbindungen, die die EF-<br />

Tu-Nucleolin Wechselwirkung vehindern,<br />

zur Verhinderung oder Behandlung von<br />

Tularämie<br />

• Use of compounds that inhibit the EF-Tunucleolin<br />

interaction for preventing or<br />

treating tularemia<br />

• Utilisation de composés qui inhibent l'interaction<br />

EF-Tu-Nucleoline pour prévenir<br />

ou traiter la tularémie<br />

(73) INSERM (Institut National de la Santé et de la<br />

Recherche Médicale), 101, rue de Tolbiac,<br />

75654 Paris Cedex 13, FR<br />

(72) Barel, Monique - INSERM U570, 156 rue de<br />

Vaugirard, 75730 Paris Cedex 15, FR<br />

Charbit, Alain - INSERM U570, 156 rue de<br />

Vaugirard, 75730 Paris Cedex 15, FR<br />

Hovanessian, Ara - UPR 2228 CNRS, <strong>45</strong> rue<br />

des Saints-Pères, 75270 Paris Cedex 06, FR<br />

Briand, Jean-Paul - UPR 9021 CNRS, 15 rue<br />

René Descartes, 67084 Strasbourg Cedex,<br />

FR<br />

(74) Holtz, Béatrice, et al, Cabinet Lavoix 2, place<br />

d'Estienne d'Orves, F-75441 Paris Cedex 09,<br />

FR<br />

(51) A61K 38/16 (11) 1 996 217 B1<br />

(25) En (26) En<br />

(21) 07752701.8 (22) 09.03.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(43) 03.12.2008<br />

(86) US 2007/006019 09.03.2007<br />

(87) WO 2007/103548 2007/37 13.09.2007<br />

(30) 09.03.2006 US 780782 P<br />

(54) • NEUARTIGE ANTIBIOTISCHE ZUSAMMEN-<br />

SETZUNGEN<br />

• NOVEL ANTIBIOTIC COMPOSITIONS<br />

• NOUVELLES PRÉPARATIONS D'ANTIBIO-<br />

TIQUES<br />

(73) Cambridge Enterprise Limited, The Old<br />

Schools, Trinity Lane Cambridge Cambridgeshire<br />

CB2 1TN, GB<br />

(72) COLEMAN, John, Richmond, British Columbia<br />

V6V 2M2, CA<br />

HAN, Kang, Richmond, British Columbia V6V<br />

2M2, CA<br />

COOPER, Matthew Allister, Cambridge, CB1<br />

3PT, GB<br />

(74) Sutcliffe, Nicholas Robert, et al, Mewburn<br />

Ellis LLP 33 Gutter Lane, London EC2V 8AS,<br />

GB<br />

A61K 38/16 → (51) A61K 33/24<br />

A61K 38/17 → (51) C07K 14/47<br />

A61K 38/17 → (51) C12N 15/12<br />

A61K 38/18 → (51) C07K 14/475<br />

A61K 38/18 → (51) C07K 14/485<br />

A61K 38/24 → (51) C07K 14/59<br />

(51) A61K 39/00 (11) 1 556 081 B1<br />

A61K 39/02 A61K 39/04<br />

A61K 39/38 C12N 15/00<br />

(25) En (26) En<br />

(21) 03755009.2 (22) 30.09.2003<br />

526<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>45</strong>/<strong>2010</strong>) 10.11.<strong>2010</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 27.07.2005<br />

(86) US 2003/030994 30.09.2003<br />

(87) WO 2004/031356 2004/16 15.04.2004<br />

(30) 30.09.2002 US 261981<br />

15.05.2003 US 439611<br />

(54) • REKOMBINANTE INTRAZELLULÄREPA-<br />

THOGEN-IMMUNOGENE ZUSAMMENSET-<br />

ZUNGEN UND ANWENDUNGSVERFAHREN<br />

• RECOMBINANT INTRACELLULAR PATHO-<br />

GEN IMMUNOGENIC COMPOSITIONS AND<br />

METHODS FOR USE<br />

• COMPOSITIONS IMMUNOGENES DE<br />

PATHOGENES INTRACELLULAIRES DE<br />

RECOMBINAISON ET LEURS METHODES<br />

D'UTILISATION<br />

(73) The Regents of The University of California,<br />

<strong>Office</strong> of Technology Transfer 1111 Franklin<br />

Street 11th Floor, Oakland, CA 94607-5200,<br />

US<br />

(72) HORWITZ, Marcus, A., Los Angeles, CA<br />

90077, US<br />

HARTH, Gunter, Los Angeles, CA 90025, US<br />

TULLIUS, Michael, V., Encino, CA 91316, US<br />

(74) Wainwright, Jane Helen, et al, Potter Clarkson<br />

LLP Park View House 58 The Ropewalk,<br />

Nottingham NG1 5DD, GB<br />

A61K 39/00 → (51) A61K 33/24<br />

A61K 39/02 → (51) A61K 39/00<br />

A61K 39/04 → (51) A61K 39/00<br />

A61K 39/09 → (51) A61K 38/10<br />

(51) A61K 39/12 (11) 1 487 483 B1<br />

A61K 39/295 A01N 63/00<br />

C12P 19/34 C12N 15/64<br />

C12N 7/00 C12N 7/04<br />

C12N 5/00<br />

C07K 17/00<br />

C12N 15/00<br />

(25) En (26) En<br />

(21) 02797280.1 (22) 11.12.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR IE IT LI LU MC NL PT SE SI SK TR<br />

AL LT LV<br />

(43) 22.12.2004<br />

(86) US 2002/039646 11.12.2002<br />

(87) WO 2003/049703 2003/25 19.06.2003<br />

(30) 12.12.2001 US 340775 P<br />

08.11.2002 US 424840 P<br />

09.12.2002 US 31<strong>45</strong>12<br />

(54) • CHIMÄRE INFEKTIÖSE DNA-KLONE VON<br />

SCHWEINE-CIRCOVIREN UND IHRE VER-<br />

WENDUNG<br />

• CHIMERIC INFECTIOUS DNA CLONES OF<br />

PORCINE CIRCOVIRUS AND USES<br />

THEREOF<br />

• CLONES D'ADN INFECTIEUX CHIMERES<br />

DE CIRCOVIRUS PORCIN ET UTILISATION<br />

DE CEUX-CI<br />

(73) VIRGINIA TECH INTELLECTUAL PROPER-<br />

TIES, INC., 2200 Kraft Drive, Suite 1050,<br />

Blacksburg, VA 24060, US<br />

IOWA STATE UNIVERSITY RESEARCH<br />

FOUNDATION, INC., 310 Lab of Mechanics,<br />

Ames, IA 50011-2131, US<br />

(72) MENG, Xiang-Jin, Blacksburg, VA 24060, US<br />

FENAUX, Martijn, Redwood City, CA 94062,<br />

US<br />

HALBUR, Patrick, G., Ames, IA 50010, US<br />

(74) Reitstötter - Kinzebach, <strong>Patent</strong>anwälte<br />

Sternwartstrasse 4, 81679 München, DE

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!